Revocation of pharmacist’s approval – Sabina Grewal (2022/04)

Overview

The National Health Act 1953, enacted by the Parliament of Australia, addresses the regulation of health services and the supply of pharmaceutical benefits in Australia. The Act was introduced to establish a framework for the efficient and effective delivery of health services, ensuring that they are accessible, affordable, and of high quality. In the case of pharmacist approvals, the Act provides mechanisms to maintain the integrity of the health system by ensuring that only qualified and compliant professionals can supply pharmaceutical benefits. On 8 April 2022, the Assistant Secretary of the Department of Health, acting as a delegate of the Minister for Health, revoked the approval of Ms Sabina Grewal to supply pharmaceutical benefits at her premises in Lindfield, NSW. This decision followed Ms Grewal’s conviction for engaging in dishonest conduct with the intent to obtain a gain from the Commonwealth, in contravention of the Criminal Code Act 1995. The revocation, effective from 8 April 2022, signifies that Ms Grewal is no longer authorised to supply pharmaceutical benefits and receive payments from the Commonwealth for such services.

Scope and Application

The National Health Act 1953 applies to individuals and entities that seek approval to supply pharmaceutical benefits in Australia. This Act applies to pharmacists such as Ms Sabina Grewal, whose approval to supply pharmaceutical benefits was revoked by a delegate of the Minister for Health and Aged Care under section 134A of the Act. The Act covers the entire Commonwealth of Australia, and its provisions extend to all states and territories. However, exclusions and exemptions are specified in the Act and can include certain circumstances where the supply of pharmaceutical benefits is not subject to the Act's requirements. The Act can also be extended or restricted through subordinate instruments, such as regulations, which may provide further detail on specific aspects of the Act's application. The revocation of Ms Grewal's approval demonstrates the Act's enforcement mechanisms and its capacity to restrict the supply of pharmaceutical benefits in cases where an approved pharmacist is convicted of certain criminal offences.

Key Provisions

The main operative sections of this revocation decision are sections 133(2)(b), 134A(1), 90, and 135.1(1) of the National Health Act 1953 and the Criminal Code Act 1995. Section 90 of the Act allows the Minister for Health to approve a pharmacist to supply pharmaceutical benefits at an approved premises. Section 133(2)(b) allows the Minister to revoke such approval on the grounds of conviction for certain offences, including those under section 135.1(1) of the Criminal Code Act 1995. Section 134A(1) of the Act requires the Minister to publish in the Gazette particulars of any revocation decision. Section 135.1(1) of the Criminal Code Act 1995 makes it an offence to engage in a course of conduct with the intention of dishonestly obtaining a gain from the Commonwealth. This decision imposes obligations on Ms Grewal and any other pharmacist who has been approved to supply pharmaceutical benefits. They must comply with the terms and conditions of their approval, including any requirements to report changes to their business or premises. They must also ensure that they do not engage in any conduct that could result in the revocation of their approval. Failure to comply with these obligations could result in the revocation of their approval and the inability to supply pharmaceutical benefits or be paid by the Commonwealth for the supply of a pharmaceutical benefit. The revocation of Ms Grewal’s approval under section 133(2)(b) of the Act is a consequence of her conviction under section 135.1(1) of the Criminal Code Act 1995. This conviction is a serious offence that carries a maximum penalty of imprisonment for 10 years or a fine of up to $210,000, or both. The revocation of Ms Grewal’s approval is a civil penalty that is intended to protect the integrity of the pharmaceutical benefits scheme and to ensure that only pharmacists who are fit and proper persons are approved to supply pharmaceutical benefits. The decision also serves as a warning to other pharmacists who may be tempted to engage in similar conduct. In summary, the revocation of Ms Grewal’s approval under the National Health Act 1953 is a serious consequence of her conviction for an offence under the Criminal Code Act 1995. The decision imposes obligations on pharmacists to comply with the terms and conditions of their approval and to avoid conduct that could result in the revocation of their approval. The revocation of Ms Grewal’s approval is a civil penalty that is intended to protect the integrity of the pharmaceutical benefits scheme and to ensure that only pharmacists who are fit and proper persons are approved to supply pharmaceutical benefits. The decision also serves as a warning to other pharmacists who may be tempted to engage in similar conduct.